A prospective multicenter, open, single design, commercial trial to evaluate the safety and efficacy of stent graft in patients with thoracic aortic dissection and aortic aneurysms

Koera University Guro Hospital0 个研究点目标入组 62 人开始时间: 待定最近更新: 2022年5月30日

适应症

试验速览

暂无简介。

•The common selection criteria are patients aged 19 or older who understand the purpose of the clinical trial and voluntarily agree and sign a written consent form.
•If this is satisfied and falls under any of A), B), C), D), and E), registration is possible.
•A) fusiform aneurysm (1) greater than 5.5 cm in diameter of thoracic aorta and (2) greater than 0.5 cm in size over 6 months from 4-5 cm or with associated clinical symptoms
•B) saccular aneurysm with risk of rupture
•C) A false aneurysm or aortic rupture
•D) aortic dissection (1) max aortic diameter greater than 4 cm (acute)/more than 6 cm (chronic) (2) substandard diameter or (A) ischemic symptoms of branched vessels (B) delamination (D) dynamic obstruction (D) cavity diameter greater than 22 mm (acute)
•E) Penetrating aortic ulcer (PAU) (1) Repeated, uncontrolled pain (2) With intramural hematoma in the thoracic aorta (3) Size of PAU >20mm in diameter or >10mm in depth

发起方

Koera University Guro Hospital